Alkem Laboratories Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Alkem Laboratories Limited generated cash of $19,480,700,000, which is more than the previous year. Cash used in financing activities reached the amount of -$11,450,100,000 last year. Net change in cash is therefore -$2,074,900,000.
Cash Flow
| 2010 | -840.92M | 419.47M | -241.76M |
|---|---|---|---|
| 2011 | 9.00B | -449.40M | -518.40M |
| 2012 | 1.18B | -3.97B | -140.91M |
| 2016 | 7.25B | 1.86B | -9.27B |
| 2018 | 2.76B | -3.67B | 845.6M |
| 2020 | 5.85B | -7.41B | 791.5M |
| 2021 | 12.64B | -9.98B | -2.71B |
| 2023 | 16.82B | 1.12B | -17.60B |
| 2024 | 19.48B | -10.08B | -11.45B |
ALKEM.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.73B | 2.32B | 1.75B | 2.49B | 1.66B | 1.39B | 14.23B | 6.61B | 7.27B |
Operating activities | |||||||||
Net income | 17.95B | 13.04B | 18.42B | 12.59B | 9.25B | 8.45B | 4.25B | 3.30B | 2.35B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 2.99B | 3.10B | 2.74B | 2.52B | 1.43B | 1.00B | 279.40M | 270.46M | 234.31M |
Stock-based compensation expense | 189.4M | 0 | 1.1M | 1.5M | 6.5M | 200K | 0 | 0 | 0 |
| Deferred income tax benefit | 189.4M | 0 | 1.1M | 1.5M | 6.5M | 200K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -2.21B | -1.34B | -257.6M | -2.57B | -5.45B | -430.1M | 0 | 0 | 0 |
Inventories | -734M | 4.73B | -4.97B | -2.81B | -2.35B | -1.18B | -692.13M | -522.14M | 202.14M |
Accounts payable | 5.25B | 145.1M | 2.12B | -37.4M | 2.93B | 2.17B | 0 | 0 | 0 |
Cash generated by operating activities | 19.48B | 16.82B | 12.64B | 5.85B | 2.76B | 7.25B | 1.18B | 9.00B | -840.92M |
Investing activities | |||||||||
Purchases Of Investments | -36.79B | -2.17B | -9.28B | -4.93B | 0 | 0 | -3.08B | 0 | 0 |
Investments In Property Plant And Equipment | -2.59B | -2.32B | -1.94B | -3.63B | -6.83B | -2.57B | -2.09B | -1.17B | -280.44M |
Acquisitions Net | 0 | 32M | 104.6M | 664.8M | 67.09M | 37.4M | 0 | 0 | 0 |
Cash generated by investing activities | -10.08B | 1.12B | -9.98B | -7.41B | -3.67B | 1.86B | -3.97B | -449.40M | 419.47M |
Financing activities | |||||||||
Common Stock Issued | 0 | 1.61B | 0 | 0 | 600K | 0 | 0 | 0 | 0 |
Payments for dividends | -5.38B | -5.29B | -3.34B | -4.39B | -2.17B | -1.84B | -209.13M | -209.13M | -174.85M |
Repurchases of common stock | 0 | 11.17B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -4.80B | -12.78B | -387.4M | 6.03B | 3.57B | -6.71B | 0 | 0 | 0 |
Cash used in financing activities | -11.45B | -17.60B | -2.71B | 791.5M | 845.6M | -9.27B | -140.91M | -518.40M | -241.76M |
Net Change In Cash | -2.07B | 416.2M | -17.2M | -731.1M | 800K | -125.6M | -2.92B | 8.03B | -663.22M |
Cash at end of period | 663.1M | 2.73B | 1.74B | 1.75B | 1.66B | 1.27B | 11.30B | 14.64B | 6.61B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |